
31 Jan 2023
VEON's Scheme becomes effective Amsterdam, Netherlands, 31 January 2023 12:30 CET: VEON Ltd. (NASDAQ, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, and its subsidiary, VEON Holdings B.V. (the Company ), confirm that, further to the announcement issued on 30 January 2023 regarding the Scheme Sanction Hearing, at which the Court made an order sanctioning the Scheme (the Order ), the Order has been delivered to the Registrar of Companies.
VEON and the Company are therefore pleased to announce that each of the conditions to the Scheme has been fulfilled in accordance with the terms of the Scheme and therefore the Scheme has become effective and binds the Company and all Scheme Creditors, including, among other things, the imposition of the Scheme Standstill, which will restrict 2023 Noteholders from taking Enforcement Action (and other related actions) in accordance with the terms described in the Scheme, as summarised in the Explanatory Statement issued by the Company on 21 December 2022, as amended on 11 January 2023.
The Amendments will only become effective if and when each of the Amendment Conditions has been satisfied or waived (in accordance with the Scheme). This includes the receipt by the Company of certain licences, and/or confirmations that no such licences are required, as set out in the Explanatory Statement (in the event that the Company determines, in its absolute discretion, that it requires such licences or confirmations).
Capitalised terms used but not defined in this announcement have the meaning given to them in the Explanatory Statement, which is available on the Scheme Website at deals.is.kroll.com/veon.
About VEON
VEON is a global digital operator that currently provides converged connectivity and online services to over 200 million customers in seven dynamic markets. We are transforming people's lives, empowering individuals, creating opportunities for greater digital inclusion and driving economic growth across countries that are home to more than 8% of the world's population. Headquartered in Amsterdam, VEON is listed on NASDAQ and Euronext.
For more information visit: https://www.veon.com.
Important Notice
This release is for informational purposes only and shall not constitute a prospectus or an offer to sell or the solicitation of an offer to buy securities in the United States or any other jurisdiction, nor shall there be any offer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under applicable securities laws.
This press release is not a prospectus for the purposes of Regulation (EU) 2017/1129.
This communication or information contained herein is not an offer, or an invitation to make offers, to sell, exchange or otherwise transfer securities in the Russian Federation to or for the benefit of any Russian person or entity and does not constitute an advertisement or offering of securities in the Russian Federation within the meaning of Russian securities laws.
Elements of this press release contain or may contain inside information as defined under the Market Abuse Regulation (EU) No. 596/2014.
Disclaimer
This release contains forward-looking statements, as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON disclaims any obligation to update them or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments.
Any steps taken in respect of the Scheme and in connection with the Amendments must be in compliance with all applicable sanctions laws and regulations, including the sanctions laws and regulations administered by the European Union, the United Kingdom and the United States, and including securing any necessary licences and approvals from competent sanctions authorities.
Contact Information
VEON
Group Director Investor Relations
Nik Kershaw
bonds@veon.com
This website stores cookies on your computer. These cookies are used to improve vour website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy
We wont track your information when you visit our site. But in order to comply with your preferences, well have to use just one tiny cookie so that youre not asked to make this choice again.
AcceptDecline
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
07/10/2026
Dalet, a leading technology and service provider for media-rich organizations, today announced the latest Long-Term Supported (LTS) release of Dalet Flex. Build...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Proven offering builds on more than 20,000 live sporting events with greater automation, flexibility, and operational control
LTN , the industry leader in tran...
06/08/2026
Hornets Tech, a specialist in broadcast connectivity and IP video, is bringing a new range of encoders, decoders and an IPTV platform to IBC2026.
Broadcast in...
06/08/2026
Introducing Adobe for ChatGPT: Create, edit and get work done - all in ChatGPT
Deepti Pradeep August 6, 2026
0 Comments
The Adobe plugin in ChatGPT br...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At IBC2026, MediaKind will make its first major appearance as a unified global powerhouse in video, showcasing one of the world's most comprehensive video i...
06/08/2026
Big Blue Marble (#5.A63) will demonstrate how its integrated technology and operational expertise help media companies scale premium services with less complexi...
06/08/2026
LA JOLLA, CA-Scripps Research has received more than $500,000 in first-year fund...
06/08/2026
LA JOLLA, CA-Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often crea...
06/08/2026
LA JOLLA, CA-The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in Alzheimer's disea...
06/08/2026
LA JOLLA, CA-Scripps Research chemist Jin-Quan Yu has been elected to the National Academy of Sciences (NAS), one of the highest honors a scientist can achieve....
06/08/2026
LA JOLLA, CA-Scripps Research ranked third in the inaugural 2026 Cure Innovation Index recognizing the top-performing institutes and centers across the United S...
06/08/2026
Benjamin Cravatt, the Gilula Chair of Chemical Biology and a professor of chemis...
06/08/2026
LA JOLLA, CA-Dennis Burton, professor and the James & Jessie Minor Chair in Immu...
06/08/2026
LA JOLLA, CA-Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translati...
06/08/2026
LA JOLLA-Scripps Research has established the Ian Wilson Endowed Chair, a new fa...
06/08/2026
Scripps Research's Skaggs Graduate School of Chemical and Biological Science...
06/08/2026
LA JOLLA, CA-Professor Jin-Quan Yu of Scripps Research has been elected to the Fellowship of the Royal Society, the U.K.'s national academy of sciences and ...
06/08/2026
LA JOLLA, CA-For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutati...
06/08/2026
LA JOLLA, CA-The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit...
06/08/2026
LA JOLLA, CA-Building the complex 3D molecules needed for new medicines has alwa...
06/08/2026
LA JOLLA, CA-Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses...
06/08/2026
LA JOLLA, CA-What do decoding communication between organs and reimagining the future of genome editing have in common? They're among the scientific questio...
06/08/2026
LA JOLLA, CA-Of the 1.2 million people living with HIV in the United States, app...
06/08/2026
LA JOLLA, CA-For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either elimi...
06/08/2026
LA JOLLA, CA-Many conditions that cause vision loss share a common feature: the ...
06/08/2026
LA JOLLA, CA-RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Crowned with the 2006 Nobel Priz...
06/08/2026
LA JOLLA, CA-The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammato...
06/08/2026
LA JOLLA, CA-Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As mor...
06/08/2026
LA JOLLA, CA-Some of the world's best-selling diabetes drugs depend on a che...
06/08/2026
LA JOLLA, CA-Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak. Technologies such as...
06/08/2026
LA JOLLA, CA-Molecular biophysicist Joan Pulupa will join Scripps Research in Ja...
06/08/2026
LA JOLLA, CA-HIV is globally so diverse, consisting of hundreds of thousands of ...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At this year's SET EXPO, PlayBox Neo will present recent innovations across its PlayBox Neo Suite and integrated range of broadcast media solutions. By show...
06/08/2026
Live demo at IBC2026 VisualOn Booth, Hall 5, Stand A55
Amsterdam, Netherlands Modern Streaming Solutions Private Limited, a rising force in India's dig...
06/08/2026
Screen Australia and YouTube Australia fund five new teams through eleventh Skip...
06/08/2026
How Karukera Studio Built a Media Production Hub with SNS EVO
Melanie Ciotti August 5, 2026
0 Comments
Hero images displays Karukera Studio in Sainte-...
06/08/2026
NHK drama series Rosanjin no Kamado shot on PYXIS 6K
Brie Clayton August 5, 2026
0 Comments
Blackmagic PYXIS 6K and DaVinci Resolve Studio capture the...
06/08/2026
Camera Match: AutoSetup 3d Plugin / script for Photomontages- Cinema 4D
Jamie Cardoso August 5, 2026
0 Comments
If you do any kind of Architectural Vi...
06/08/2026
In Time airs Monday 10 August at 9.35pm on RT One and RT Player
In Time is the first film account of the life of D nal Lunny, one of the most influential Iri...
06/08/2026
Editor's note: This post is part of Into the Omniverse, a series focused on how developers, 3D practitioners and enterprises can transform their workflows u...